BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26283964)

  • 1. Urokinase receptor and resistance to targeted anticancer agents.
    Gonias SL; Hu J
    Front Pharmacol; 2015; 6():154. PubMed ID: 26283964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
    Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
    J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.
    Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
    Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis.
    Shmakova AA; Klimovich PS; Rysenkova KD; Popov VS; Gorbunova AS; Karpukhina AA; Karagyaur MN; Rubina KA; Tkachuk VA; Semina EV
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
    Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.
    Lester RD; Jo M; Montel V; Takimoto S; Gonias SL
    J Cell Biol; 2007 Jul; 178(3):425-36. PubMed ID: 17664334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.
    Gilder AS; Natali L; Van Dyk DM; Zalfa C; Banki MA; Pizzo DP; Wang H; Klemke RL; Mantuano E; Gonias SL
    Sci Rep; 2018 Feb; 8(1):2982. PubMed ID: 29445239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
    Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.
    van Veen M; Matas-Rico E; van de Wetering K; Leyton-Puig D; Kedziora KM; De Lorenzi V; Stijf-Bultsma Y; van den Broek B; Jalink K; Sidenius N; Perrakis A; Moolenaar WH
    Elife; 2017 Aug; 6():. PubMed ID: 28849762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
    Hau AM; Leivo MZ; Gilder AS; Hu JJ; Gonias SL; Hansel DE
    Cell Signal; 2017 Jan; 29():96-106. PubMed ID: 27777073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1).
    Gonias SL; Gaultier A; Jo M
    Curr Pharm Des; 2011; 17(19):1962-9. PubMed ID: 21711236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of uPAR is required for cigarette smoke extract-induced epithelial-mesenchymal transition in lung epithelial cells.
    Wang Q; Wang H; Zhang Y; Zhang Y; Xiao W
    Oncol Res; 2013; 21(6):295-305. PubMed ID: 25198659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.
    Wang Y
    Med Res Rev; 2001 Mar; 21(2):146-70. PubMed ID: 11223863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.